Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints

Oncogene

Volumn 27, Issue 20, 2008, Pages 2923-2928

  Dong, W ^a   Arpin, C ^b,c,d   Accardi, R ^a   Gissmann, L ^e   Sylla, B S ^a   Marvel, J ^b,c,d   Tommasino, M ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b INSERM   (France)

^c University Lyon i   (France)

^d UNIVERSITÉ LYON 1   (France)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Np73; Cell cycle checkpoints; HPV38; Transgenic mice; UV irradiation

Indexed keywords

BETA ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN E6; PROTEIN E7; PROTEIN P53; PROTEIN P73;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL CYCLE ARREST; CELL CYCLE REGULATION; CONTROLLED STUDY; HUMAN PAPILLOMAVIRUS TYPE 38; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; ULTRAVIOLET IRRADIATION; WART VIRUS;

ANIMALS; BETAPAPILLOMAVIRUS; CELL CYCLE; CELLS, CULTURED; DNA-BINDING PROTEINS; GENES, P53; HUMANS; KERATINOCYTES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NUCLEAR PROTEINS; PAPILLOMAVIRUS E7 PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 38; MUS; MUS MUSCULUS;

EID: 42949121525     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210944     Document Type: Article

References (12)

1. Accardi R, Dong W, Smet A, Cui R, Hautefeuille A, Gabet AS et al. (2006). Skin human papillomavirus type38 alters p53 functions by accumulation of deltaNp73. EMBO R 7: 334-340.
2. Akgul B, Garcia-Escudero R, Ghali L, Pfister HJ, Fuchs PG, Navsaria H et al. (2005). The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res 65: 2216-2223.
3. Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarre M et al. (2003). The E6 and E7 proteins of cutaneous human papillomavirus type38 display transforming properties. J Virol 77: 2195-2206.
4. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. (2004). Classification of papillomaviruses. Virology 324: 17-27.
5. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
6. Dong W, Kloz U, Accardi R, Caldeira S, Tong WM, Wang ZQ et al. (2005). Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type38. J Virol 79: 14899-14908.
7. Jackson S, Harwood C, Thomas M, Banks L, Storey A. (2000). Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14: 3065-3073.
8. Michel A, Kopp-Schneider A, Zentgraf H, Gruber AD, de Villiers EM. (2006). E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice. J Virol 80: 11153-11164.
9. Pfister H. (2003). Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31: 52-56.
10. Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, Smyth N et al. (2005). Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 65: 1394-1400.
11. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J et al. (2000). p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404: 99-103.
12. zur Hausen H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.